Drug Profile


Alternative Names: Dotaricin; FI 6026

Latest Information Update: 12 Dec 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferrer
  • Developer Azwell; Ferrer; Kayaku; Mylan Laboratories
  • Class Antimigraines; Piperazines
  • Mechanism of Action Calcium channel antagonists; Serotonin 1C receptor antagonists; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Migraine; Stroke; Vertigo

Most Recent Events

  • 18 Jan 2001 Discontinued-II for Migraine in USA (Unknown route)
  • 18 Jan 2001 Discontinued-III for Migraine in Switzerland (Unknown route)
  • 18 Jan 2001 Discontinued-Preclinical for Migraine in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top